Literature DB >> 9778263

Slow vertical saccades in motor neuron disease: correlation of structure and function.

L Averbuch-Heller1, C Helmchen, A K Horn, R J Leigh, J A Büttner-Ennerver.   

Abstract

We studied eye movements and brainstem pathology in 2 patients with slow vertical saccades and autopsy-proven amyotrophic lateral sclerosis (ALS). In both patients, the main ocular motor finding was supranuclear vertical gaze impairment with slow vertical saccades. The second patient had difficulty opening his eyes on command, with preserved spontaneous eyelid opening. Postmortem examination in both patients demonstrated cell loss in the rostral interstitial nucleus of the medial longitudinal fasciculus (riMLF) and substantia nigra, along with histopathological findings consistent with ALS. The extent of the pathological changes in the riMLF correlated well with the degree of functional impairment as reflected in the slow vertical saccades. We suggest that motor neuron disease with early involvement of vertical saccades represents a distinct clinicopathological entity.

Entities:  

Mesh:

Year:  1998        PMID: 9778263     DOI: 10.1002/ana.410440410

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  29 in total

Review 1.  Vertical supranuclear gaze palsy in Niemann-Pick type C disease.

Authors:  Ettore Salsano; Chizoba Umeh; Alessandra Rufa; Davide Pareyson; David S Zee
Journal:  Neurol Sci       Date:  2012-07-19       Impact factor: 3.307

2.  Clinicopathologic report of ocular involvement in ALS patients with C9orf72 mutation.

Authors:  Amani A Fawzi; Joseph M Simonett; Patryk Purta; Heather E Moss; Jessica L Lowry; Han-Xiang Deng; Nailah Siddique; Robert Sufit; Eileen H Bigio; Nicholas J Volpe; Teepu Siddique
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-10-16       Impact factor: 4.092

3.  A Supranuclear Disorder of Ocular Motility as a Rare Initial Presentation of Motor Neurone Disease.

Authors:  C Yu-Wai-Man; K Petheram; A W Davidson; T Williams; P G Griffiths
Journal:  Neuroophthalmology       Date:  2011-01-16

4.  Slow saccades in bulbar-onset motor neurone disease.

Authors:  Colette Donaghy; Ralph Pinnock; Sharon Abrahams; Chris Cardwell; Orla Hardiman; Victor Patterson; R Canice McGivern; J Mark Gibson
Journal:  J Neurol       Date:  2010-02-10       Impact factor: 4.849

5.  Ophthalmic Manifestations of Amyotrophic Lateral Sclerosis (An American Ophthalmological Society Thesis).

Authors:  Nicholas J Volpe; Joseph Simonett; Amani A Fawzi; Teepu Siddique
Journal:  Trans Am Ophthalmol Soc       Date:  2015

6.  Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population.

Authors:  Heather E Moss; Leo McCluskey; Lauren Elman; Katelin Hoskins; Lauren Talman; Murray Grossman; Laura J Balcer; Steven L Galetta; Grant T Liu
Journal:  J Neurol Sci       Date:  2011-12-21       Impact factor: 3.181

7.  Slow vertical saccades in the frontotemporal dementia with motor neuron disease.

Authors:  S Y Moon; B H Lee; S W Seo; S J Kang; D L Na
Journal:  J Neurol       Date:  2008-09-25       Impact factor: 4.849

8.  Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis.

Authors:  John Ravits; Stanley Appel; Robert H Baloh; Richard Barohn; Benjamin Rix Brooks; Lauren Elman; Mary Kay Floeter; Christopher Henderson; Catherine Lomen-Hoerth; Jeffrey D Macklis; Leo McCluskey; Hiroshi Mitsumoto; Serge Przedborski; Jeffrey Rothstein; John Q Trojanowski; Leonard H van den Berg; Steven Ringel
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05       Impact factor: 4.092

Review 9.  Eye movements in patients with neurodegenerative disorders.

Authors:  Tim J Anderson; Michael R MacAskill
Journal:  Nat Rev Neurol       Date:  2013-01-22       Impact factor: 42.937

10.  Toward a high-throughput auditory P300-based brain-computer interface.

Authors:  D S Klobassa; T M Vaughan; P Brunner; N E Schwartz; J R Wolpaw; C Neuper; E W Sellers
Journal:  Clin Neurophysiol       Date:  2009-07-01       Impact factor: 3.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.